108 related articles for article (PubMed ID: 16570199)
1. Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infection.
de Castro AM; Luquetti AO; Rassi A; Chiari E; Galvão LM
Parasitol Res; 2006 Sep; 99(4):379-83. PubMed ID: 16570199
[TBL] [Abstract][Full Text] [Related]
2. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
[TBL] [Abstract][Full Text] [Related]
3. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
4. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
[TBL] [Abstract][Full Text] [Related]
5. 4-nitrobenzoylcoumarin potentiates the antiparasitic, anti-inflammatory and cardioprotective effects of benznidazole in a murine model of acute Trypanosoma cruzi infection.
Vilas-Boas DF; Oliveira RRG; Gonçalves-Santos E; Silva LS; Diniz LF; Mazzeti AL; Brancaglion GA; Carvalho DT; Caldas S; Novaes RD; Caldas IS
Acta Trop; 2022 Apr; 228():106314. PubMed ID: 35038424
[TBL] [Abstract][Full Text] [Related]
6. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
8. Sesquiterpene lactone potentiates the immunomodulatory, antiparasitic and cardioprotective effects on anti-Trypanosoma cruzi specific chemotherapy.
Gonçalves-Santos E; Vilas-Boas DF; Diniz LF; Veloso MP; Mazzeti AL; Rodrigues MR; Oliveira CM; Fernandes VHC; Novaes RD; Chagas-Paula DA; Caldas IS
Int Immunopharmacol; 2019 Dec; 77():105961. PubMed ID: 31685438
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR as a marker for preemptive therapy and its role in therapeutic control in Trypanosoma cruzi/HIV coinfection.
Freitas VLT; Novaes CTG; Sartori AMC; Carvalho NB; Silva SCVD; Nakanishi ÉS; Salvador F; Castro CN; Bezerra RC; Westphalen EVN; Oliveira CMR; Busser FD; Ho YL; Buccheri R; Bonilla C; Shikanai-Yasuda MA
PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011961. PubMed ID: 38408095
[TBL] [Abstract][Full Text] [Related]
10. [Trypanosoma cruzi high parasitemia in patient with systemic lupus erythematosus].
dos Santos-Neto LL; Polcheira MF; Castro C; Lima RA; Simaan CK; Corrêa-Lima FA
Rev Soc Bras Med Trop; 2003; 36(5):613-5. PubMed ID: 14576877
[TBL] [Abstract][Full Text] [Related]
11. The Anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas' disease is less dependent on gamma interferon than that of benznidazole.
Ferraz ML; Gazzinelli RT; Alves RO; Urbina JA; Romanha AJ
Antimicrob Agents Chemother; 2007 Apr; 51(4):1359-64. PubMed ID: 17220408
[TBL] [Abstract][Full Text] [Related]
12. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma and Chagas disease: qPCR as a marker for preemptive antiparasitic therapy: a case reports series and review.
Carvalho NB; Freitas VLT; Seguro FS; Bezerra RC; Fatobene G; Nakanishi ÉYS; Visnadi H; Martinez G; Batista MV; Rocha V; Dulley FL; Costa SF; Shikanai-Yasuda MA
Rev Inst Med Trop Sao Paulo; 2024; 66():e10. PubMed ID: 38324876
[TBL] [Abstract][Full Text] [Related]
14. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
15. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
[TBL] [Abstract][Full Text] [Related]
17. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
[TBL] [Abstract][Full Text] [Related]
18. PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.
Galvão LM; Chiari E; Macedo AM; Luquetti AO; Silva SA; Andrade AL
J Clin Microbiol; 2003 Nov; 41(11):5066-70. PubMed ID: 14605140
[TBL] [Abstract][Full Text] [Related]
19. Detection and treatment of Trypanosoma cruzi: a patent review (2011-2015).
Rodriguez JB; Falcone BN; Szajnman SH
Expert Opin Ther Pat; 2016 Sep; 26(9):993-1015. PubMed ID: 27376456
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
